Dernière mise à jour : 04/02/2025
The new text (Final Rule) published by the FDA on February 2, 2024 amending the Current Good Manufacturing Practice (CGMP) requirements documented in 21 CFR Part 820 of the Quality System Regulation (QSR), incorporates by reference the ISO 13485: 2016 standard. The new requirements, known as the Quality Management System Regulation (QMSR), come into force on 02/02/2026.
It enables participants to understand the requirements for implementing or improving a QMS in order to comply with QMSR.
MODULE 1: Background to medical device regulation in the US.
Module objectives: Understand the regulatory context in which the FDA has published the final rule (QMSR), know the main GAPs between QSR, QMSR and ISO 13485: 2016 and present the 2 key ISO 13185: 2016 approaches (process approach and Risk-based approach).
MODULE 2 : Quality Management System (according to ISO 13485: 2016)
Module objectives: Know and understand the requirements of ISO 13485: 2016 incorporated by reference.
MODULE 3 : Management responsibility
Module objectives: understand the responsibilities of top management as defined by ISO 13485: 2016.
MODULE 4 : Resource management
Module objectives: understand the standard's requirements for resource management.
MODULE 5 : Product realization
Module objectives: Understand the requirements of ISO 13485: 2016 with regard to the product
realization process, the management design changes, and the importance of risk management along the entire product realization process.
MODULE 6 : Measurement and improvement
Module objectives: Understand the requirements of ISO 13485: 2016 concerning analysis and improvement, and acquire tools for managing non-conformities and corrective and preventive actions.
Alternating theory, case studies and games.
Training support in English.
Training presentation in French or English.